0001179110-20-001026.txt : 20200204 0001179110-20-001026.hdr.sgml : 20200204 20200204172452 ACCESSION NUMBER: 0001179110-20-001026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200131 FILED AS OF DATE: 20200204 DATE AS OF CHANGE: 20200204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Albright Charles CENTRAL INDEX KEY: 0001682323 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 20574988 MAIL ADDRESS: STREET 1: 87 MILL ROAD CITY: MADISON STATE: CT ZIP: 06443 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 edgar.xml FORM 4 - X0306 4 2020-01-31 0 0001650664 Editas Medicine, Inc. EDIT 0001682323 Albright Charles C/O EDITAS MEDICINE, INC. 11 HURLEY ST. CAMBRIDGE MA 02141 0 1 0 0 Chief Scientific Officer Common Stock 2020-01-31 4 M 0 17977 0 A 26102 D Common Stock 2020-02-03 4 S 0 5549 26.5431 D 20553 D Restricted Stock Units 0 2020-01-31 4 M 0 17977 0 D Common Stock 17977 0 D The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, which vested in full on January 31, 2020. Such amount includes common stock received by the Reporting Person in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, which is scheduled to vest over four years with 25% of the units vesting on February 6, 2020 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2023, which was previously reported on Table II of a Form 4 filed by the Reporting Person with the SEC on February 8, 2019. The sales reported in this Form 4 were effected pursuant to an durable automatic sales instruction plan adopted by the Reporting Person on May 11, 2019, and represent the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on January 31, 2020. The sales do not represent a discretionary trade by the Reporting Person. The restricted stock unit award vested in full on January 31, 2020. /s/ Charles Albright 2020-02-04